
World's First AI-Designed Vaccine Enters Human Trials
Scientists from Cambridge have developed the world's first vaccine designed with artificial intelligence, which has now entered human trials. This groundbreaking vaccine targets coronaviruses and represents a significant advancement in medical technology.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Excellent (92/100)Sources
'World-first' vaccine designed by Artificial Intelligence
Cambridge scientists say they have, for the first time, tested a vaccine designed by AI.
Read full article →AI ‘super-antigen’ vaccine could protect against whole families of viruses
Researchers say this could prevent future pandemics, save lives and stop lockdowns
By Storm Newton
Read full article →World's first AI-designed vaccine developed by UK scientists enters human trials
A groundbreaking AI-designed vaccine for Crimean-Congo haemorrhagic fever has entered human trials, marking a world-first for medical research. Developed by Oxford University and Basecamp Research, this initiative showcases AI's potential to drastically accelerate vaccine development for emerging infectious diseases. The trial aims to assess safety and immune response, potentially ushering in a new era of AI-assisted medicine.
By TOI World Desk
Read full article →Cambridge scientists develop first ‘AI vaccine’ against coronaviruses. Here’s how it works
Read full article →‘World-first’ vaccine designed by artificial intelligence
Artificial intelligence has been used to develop a "fundamentally new" type of vaccine that could protect against large swathes of viruses and prevent pandemics, say researchers.
By Abubakar Ibrahim
Read full article →


